Diagnostic News and Research

RSS

Komen Advocacy Alliance thanks Congress for 6-month extension of enhanced federal funding for Medicaid

The Susan G. Komen for the Cure® Advocacy Alliance thanked Congress and the Administration for a six-month extension of enhanced federal funding for Medicaid, which was signed into law Tuesday night. The additional federal aid will help stave off potential cuts to programs that provide breast cancer screening and treatment for underserved women.

12 Aug 2010

AdvanDx announces European launch of CE-IVD marked GNR Traffic Light PNA FISH test

AdvanDx today announced the launch of its CE-IVD marked GNR Traffic Light™ PNA FISH® test in Europe. GNR Traffic Light PNA FISH is the first-ever test capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from positive blood cultures in less than 90 minutes.

12 Aug 2010

RadNet completes acquisition of Health Diagnostics' New Jersey subsidiary

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has completed the previously announced acquisition of the New Jersey operating subsidiary of Health Diagnostics.

12 Aug 2010

K-State researcher receives grant from NIH to continue cancer research

Understanding how cancer cells communicate with each other and how to enhance their receptiveness to drug treatments is the focus of promising work by a Kansas State University researcher.Annelise Nguyen, assistant professor of toxicology in the department of diagnostic medicine and pathobiology at K-State's College of Veterinary Medicine, recently received a $370,000 grant from the National Institutes of Health to continue her cancer research.

12 Aug 2010

Isotechnika second-quarter revenue from continuing operations increases to $1.49 million

Isotechnika Pharma Inc. today announced financial results for the second quarter ended June 30, 2010.

12 Aug 2010

Swift Biosciences completes $3 million Series A financing

Swift Biosciences Inc., a Michigan-based life sciences company, today announced the recent completion of a $3 million Series A financing led by the venture firm DFJ Mercury. DFJ Mercury was joined in the Series A by several Michigan-based individual investors who also helped launch the Company with seed funding in January 2010. Daniel Watkins of DFJ Mercury will join the company's Board of Directors.

12 Aug 2010

ACR announces revised classification criteria for rheumatoid arthritis

The American College of Rheumatology announced the release of revised classification criteria (created in collaboration with the European League Against Rheumatism) for rheumatoid arthritis, which will allow the study of treatments for RA at much earlier stages of the disease—before joint damage occurs—ultimately leading to better patient outcomes.

11 Aug 2010

Protagen granted Notice of Allowance in Japan for key method patent for identifying and selecting clones

Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis, announced today that it received a Notice of Allowance by the Japanese Patent Office stating a favourable decision for the patent application 2000-547262 developed at the Max-Planck Institute for Molecular Genetics in Berlin, Germany. This patent claims broadly a method for identifying and selecting clones relating to the basic UNIclone® technology and is already granted in Europe with the publication number EP1073770 B1.

11 Aug 2010

Stanford Hospital & Clinics establishes Kidney and Pancreas Transplant Clinic at Salinas Valley Memorial

The partnership between Salinas Valley Memorial Healthcare System and Stanford Hospital & Clinics has added another facet of care, bringing world-class organ transplant care to patients on the Central Coast. Stanford's Adult Kidney and Pancreas Transplant Program will begin seeing patients at Salinas Valley Memorial's Ryan Ranch facility.

11 Aug 2010

SMI/Omega development team receives fund to develop prototype fast multispectral endoscope

Cascade Technologies, Inc., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will receive NIH research funding through a collaboration with Omega Optical of Brattleboro, Vermont. This effort will accelerate development of a new class of medical endoscopes enhanced with proprietary multispectral imaging technology. The principal investigators on the project are Dr. Gary Carver, Director of Research at Omega Optical, and Dr. Daniel L. Farkas, Chairman and CEO of SMI.

11 Aug 2010

Stoecker and Associates develops new software for early diagnosis of malignant melanoma

Detection of malignant melanoma, the most serious type of skin cancer, will soon be quicker and easier thanks to the work of researchers at Missouri University of Science and Technology.The research, which is funded by the National Institutes of Health, recently received a patent titled "Automatic Detection of Critical Dermoscopy Features for Malignant Melanoma Diagnosis." The patent applies to a method for computer-aided analysis of photographs of skin lesions to detect the cancer. Melanoma can be cured if it is diagnosed early enough.

11 Aug 2010

Magnetic resonance image analysis helps assessment of prostate cancer severity

Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.

11 Aug 2010

Myriad Genetics fourth-quarter revenues increase 9% to $93.9 million

Myriad Genetics, Inc. today reported financial results for its fourth quarter and fiscal year ended June 30, 2010.

11 Aug 2010

Acoustic cardiography improves diagnostic accuracy in acute heart failure

It allows them to hear the S3, an abnormal third sound in the heart's rhythm strongly associated with cardiac disease and heart failure. However, the low-frequency, low-pitch sound is notoriously very difficult to hear with a stethoscope alone.It allows them to hear the S3, an abnormal third sound in the heart's rhythm strongly associated with cardiac disease and heart failure. However, the low-frequency, low-pitch sound is notoriously very difficult to hear with a stethoscope alone.

11 Aug 2010

Clarient receives patent for Mammostrat breast cancer prognostic test

Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.

11 Aug 2010

ACD launches RNAscope Formalin-Fixed, Paraffin-Embedded Assay Kit

Advanced Cell Diagnostics, Inc., announces the launch and immediate availability of RNAscope™ FFPE Assay Kit, a line of RUO products designed to detect RNA biomarkers in routine Formalin-Fixed, Paraffin-Embedded tissue specimens with single molecule sensitivity.

From Advanced Cell Diagnostics 11 Aug 2010

Graymark Healthcare second-quarter consolidated net revenues increase 12% to $28.3 million

Graymark Healthcare, Inc. today announced financial results for the quarter ending June 30, 2010 including $1.1MM of EBITDA on $28.3MM in sales.

10 Aug 2010

Language Line University offers new scalable online training tool for medical interpreters

Language Line(R) University, the interpreter assessment and training division of Language Line Services, an over-the-phone and video interpretation services provider, is offering a new scalable online training tool for medical interpreters. LLU Web Advanced Medical Training for Interpreters, the first of its kind in the industry, combines 15 hours of self-paced Web activities with 10 hours of live over-the-phone instructor-led sessions. Completion of the course qualifies participants to receive 10 continuing education points from the American Translators Association.

10 Aug 2010

China Sky One second-quarter 2010 total revenues up 26.7%

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced record financial results for the second quarter of 2010.

10 Aug 2010

Epitomics launches EP Clone Rabbit Monoclonal Antibodies

Epitomics, Inc., the rabbit monoclonal antibody company, announces today the launch of EP Clone™ Rabbit Monoclonal Antibodies and their detection systems for pathology applications. These diagnostic immunohistochemistry (IHC) products are manufactured by the In Vitro Diagnostic (IVD) Division of the Company. This new line of products are developed in compliance with regulation for IHC antibodies and detection systems in the United States, these products are manufactured under FDA's Quality System Regulation (21 CFR, Part 820).

9 Aug 2010

Diagnostic News and Research

Komen Advocacy Alliance thanks Congress for 6-month extension of enhanced federal funding for Medicaid

AdvanDx announces European launch of CE-IVD marked GNR Traffic Light PNA FISH test

RadNet completes acquisition of Health Diagnostics' New Jersey subsidiary

K-State researcher receives grant from NIH to continue cancer research

Isotechnika second-quarter revenue from continuing operations increases to $1.49 million

Swift Biosciences completes $3 million Series A financing

ACR announces revised classification criteria for rheumatoid arthritis

Protagen granted Notice of Allowance in Japan for key method patent for identifying and selecting clones

Stanford Hospital & Clinics establishes Kidney and Pancreas Transplant Clinic at Salinas Valley Memorial

SMI/Omega development team receives fund to develop prototype fast multispectral endoscope

Stoecker and Associates develops new software for early diagnosis of malignant melanoma

Magnetic resonance image analysis helps assessment of prostate cancer severity

Myriad Genetics fourth-quarter revenues increase 9% to $93.9 million

Acoustic cardiography improves diagnostic accuracy in acute heart failure

Clarient receives patent for Mammostrat breast cancer prognostic test

ACD launches RNAscope Formalin-Fixed, Paraffin-Embedded Assay Kit

Graymark Healthcare second-quarter consolidated net revenues increase 12% to $28.3 million

Language Line University offers new scalable online training tool for medical interpreters

China Sky One second-quarter 2010 total revenues up 26.7%

Epitomics launches EP Clone Rabbit Monoclonal Antibodies

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News